Protecting Our Pharmaceutical Supply Chain from China Act of 2020
Sponsored By: Representative Gallagher, Mike [R-WI-8]
Unknown
Summary
Protecting Our Pharmaceutical Supply Chain from China Act of 2020 This bill requires the federal government to maintain a registry of certain foreign-sourced drugs, prohibits federal health care programs from purchasing drugs containing Chinese ingredients, requires drugs to be labeled for country of origin, and offers domestic manufacturing facility tax incentives.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & CoSponsors
Sponsor
Gallagher, Mike [R-WI-8]
WI • R
Cosponsors
Rep. Cheney, Liz [R-WY-At Large]
WY • R
Sponsored 4/10/2020
Rep. Stefanik, Elise M. [R-NY-21]
NY • R
Sponsored 4/10/2020
Sen. Budd, Ted [R-NC]
NC • R
Sponsored 4/10/2020
Rep. Van Drew, Jefferson [R-NJ-2]
NJ • R
Sponsored 4/28/2020
Rep. Hartzler, Vicky [R-MO-4]
MO • R
Sponsored 5/8/2020
Rep. Posey, Bill [R-FL-8]
FL • R
Sponsored 5/8/2020
Resident Commissioner González-Colón, Jenniffer [R-PR-At Large]
PR • R
Sponsored 5/15/2020
Rep. Biggs, Andy [R-AZ-5]
AZ • R
Sponsored 5/22/2020
Rep. Lesko, Debbie [R-AZ-8]
AZ • R
Sponsored 6/8/2020
Rep. Baird, James R. [R-IN-4]
IN • R
Sponsored 7/1/2020
Rep. Turner, Michael R. [R-OH-10]
OH • R
Sponsored 10/27/2020
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov